New Illumina launch seen to rejuvenate thawing sales: analysts

(Reuters) - Shares of Illumina Inc rose 14 percent in premarket trading on Tuesday, after the maker of products used for genetic analysis launched its newest gene-sequencing platform, prompting a slew of analyst price target increases.